

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 8.33242909 |
| 2 | regulation of guanylate cyclase activity (GO:0031282) | 8.10079082 |
| 3 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.14403082 |
| 4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.00785481 |
| 5 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.56280982 |
| 6 | negative regulation of epidermis development (GO:0045683) | 6.49988254 |
| 7 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.36802811 |
| 8 | maintenance of protein location in nucleus (GO:0051457) | 6.16261595 |
| 9 | somite rostral/caudal axis specification (GO:0032525) | 6.13857253 |
| 10 | cytidine metabolic process (GO:0046087) | 6.00085210 |
| 11 | cytidine catabolic process (GO:0006216) | 6.00085210 |
| 12 | cytidine deamination (GO:0009972) | 6.00085210 |
| 13 | positive regulation of respiratory burst (GO:0060267) | 5.96516466 |
| 14 | intestinal epithelial cell development (GO:0060576) | 5.90150585 |
| 15 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.89062638 |
| 16 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.82978854 |
| 17 | regulation of response to osmotic stress (GO:0047484) | 5.75115770 |
| 18 | regulation of cellular extravasation (GO:0002691) | 5.63220911 |
| 19 | NADH metabolic process (GO:0006734) | 5.62979997 |
| 20 | protein localization to kinetochore (GO:0034501) | 5.53598512 |
| 21 | hormone catabolic process (GO:0042447) | 5.44707094 |
| 22 | negative regulation of epidermal cell differentiation (GO:0045605) | 5.44130722 |
| 23 | negative regulation of telomerase activity (GO:0051974) | 5.36981231 |
| 24 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.30279343 |
| 25 | muscle organ morphogenesis (GO:0048644) | 5.29160404 |
| 26 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.21118227 |
| 27 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.21118227 |
| 28 | endocrine process (GO:0050886) | 5.21118227 |
| 29 | vitamin A metabolic process (GO:0006776) | 5.16605578 |
| 30 | antibacterial humoral response (GO:0019731) | 5.13213447 |
| 31 | lipoprotein transport (GO:0042953) | 5.10948211 |
| 32 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.07422425 |
| 33 | phenol-containing compound catabolic process (GO:0019336) | 5.05948377 |
| 34 | regulation of bile acid biosynthetic process (GO:0070857) | 5.03724976 |
| 35 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.99097248 |
| 36 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.98176175 |
| 37 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.97769103 |
| 38 | regulation of cGMP biosynthetic process (GO:0030826) | 4.97092207 |
| 39 | notochord development (GO:0030903) | 4.95826597 |
| 40 | heterochromatin organization (GO:0070828) | 4.94352300 |
| 41 | antimicrobial humoral response (GO:0019730) | 4.94286471 |
| 42 | cellular glucuronidation (GO:0052695) | 4.93007845 |
| 43 | GDP-mannose metabolic process (GO:0019673) | 4.92189177 |
| 44 | glucuronate metabolic process (GO:0019585) | 4.88332640 |
| 45 | uronic acid metabolic process (GO:0006063) | 4.88332640 |
| 46 | rRNA transcription (GO:0009303) | 4.85511421 |
| 47 | bile acid and bile salt transport (GO:0015721) | 4.84802192 |
| 48 | positive regulation of pseudopodium assembly (GO:0031274) | 4.78304708 |
| 49 | regulation of systemic arterial blood pressure (GO:0003073) | 4.70659003 |
| 50 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.64783979 |
| 51 | histone H4-K8 acetylation (GO:0043982) | 4.55756356 |
| 52 | histone H4-K5 acetylation (GO:0043981) | 4.55756356 |
| 53 | regulation of cilium movement (GO:0003352) | 4.54325355 |
| 54 | histone H4-K12 acetylation (GO:0043983) | 4.53924067 |
| 55 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.52968970 |
| 56 | glomerular filtration (GO:0003094) | 4.44311050 |
| 57 | nucleoside transmembrane transport (GO:1901642) | 4.43515871 |
| 58 | mitotic sister chromatid segregation (GO:0000070) | 4.42876105 |
| 59 | renal system process involved in regulation of blood volume (GO:0001977) | 4.40992860 |
| 60 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.38287626 |
| 61 | rRNA methylation (GO:0031167) | 4.34179265 |
| 62 | regulation of pseudopodium assembly (GO:0031272) | 4.28583321 |
| 63 | regulation of respiratory burst (GO:0060263) | 4.24644524 |
| 64 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.23586226 |
| 65 | drug metabolic process (GO:0017144) | 4.21469035 |
| 66 | regulation of vitamin metabolic process (GO:0030656) | 4.17552086 |
| 67 | quinone metabolic process (GO:1901661) | 4.17193863 |
| 68 | regulation of cGMP metabolic process (GO:0030823) | 4.17089885 |
| 69 | sulfate transmembrane transport (GO:1902358) | 4.14803011 |
| 70 | rRNA modification (GO:0000154) | 4.12884293 |
| 71 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.12482002 |
| 72 | protein localization to chromosome, centromeric region (GO:0071459) | 4.07388527 |
| 73 | transepithelial transport (GO:0070633) | 4.05671701 |
| 74 | regulation of translation in response to stress (GO:0043555) | 4.05418181 |
| 75 | oligosaccharide biosynthetic process (GO:0009312) | 4.05336065 |
| 76 | chromatin assembly (GO:0031497) | 4.00321416 |
| 77 | renal filtration (GO:0097205) | 3.98311053 |
| 78 | epoxygenase P450 pathway (GO:0019373) | 3.97608573 |
| 79 | adhesion of symbiont to host cell (GO:0044650) | 3.97585560 |
| 80 | virion attachment to host cell (GO:0019062) | 3.97585560 |
| 81 | diacylglycerol metabolic process (GO:0046339) | 3.95730343 |
| 82 | fructose metabolic process (GO:0006000) | 3.93424408 |
| 83 | interferon-gamma production (GO:0032609) | 3.93254938 |
| 84 | response to dietary excess (GO:0002021) | 3.91774344 |
| 85 | trophectodermal cell differentiation (GO:0001829) | 3.91433631 |
| 86 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.89365636 |
| 87 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.89141258 |
| 88 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.88591873 |
| 89 | arginine metabolic process (GO:0006525) | 3.87913086 |
| 90 | cardiovascular system development (GO:0072358) | 3.87639167 |
| 91 | digestion (GO:0007586) | 3.84588292 |
| 92 | primitive streak formation (GO:0090009) | 3.84509894 |
| 93 | DNA replication checkpoint (GO:0000076) | 3.83631905 |
| 94 | transcytosis (GO:0045056) | 3.82648420 |
| 95 | coenzyme catabolic process (GO:0009109) | 3.79750581 |
| 96 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.79197119 |
| 97 | urea cycle (GO:0000050) | 3.77746858 |
| 98 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.73812993 |
| 99 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.70965840 |
| 100 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.70965840 |
| 101 | intestinal absorption (GO:0050892) | 3.67049325 |
| 102 | cellular modified amino acid catabolic process (GO:0042219) | 3.64729727 |
| 103 | eosinophil chemotaxis (GO:0048245) | 3.62010888 |
| 104 | sister chromatid segregation (GO:0000819) | 3.60498339 |
| 105 | negative regulation of telomere maintenance (GO:0032205) | 3.60004156 |
| 106 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.57456195 |
| 107 | urea metabolic process (GO:0019627) | 3.56868355 |
| 108 | icosanoid secretion (GO:0032309) | 3.56007832 |
| 109 | arachidonic acid secretion (GO:0050482) | 3.56007832 |
| 110 | peptide hormone processing (GO:0016486) | 3.55489256 |
| 111 | ethanol oxidation (GO:0006069) | 3.55470455 |
| 112 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.53713895 |
| 113 | regulation of triglyceride catabolic process (GO:0010896) | 3.50854773 |
| 114 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.50400491 |
| 115 | nucleoside transport (GO:0015858) | 3.49675307 |
| 116 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.48561665 |
| 117 | maintenance of protein localization in organelle (GO:0072595) | 3.47192583 |
| 118 | alkaloid metabolic process (GO:0009820) | 3.46747644 |
| 119 | phenylpropanoid metabolic process (GO:0009698) | 3.46520486 |
| 120 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.45175730 |
| 121 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.44774846 |
| 122 | digestive system process (GO:0022600) | 3.44211875 |
| 123 | glycolipid catabolic process (GO:0019377) | 3.43181172 |
| 124 | glycosphingolipid catabolic process (GO:0046479) | 3.40378688 |
| 125 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.37340820 |
| 126 | auditory receptor cell differentiation (GO:0042491) | 3.36841768 |
| 127 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.34524652 |
| 128 | drug catabolic process (GO:0042737) | 3.34397792 |
| 129 | sulfate transport (GO:0008272) | 3.32281271 |
| 130 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.32217045 |
| 131 | primary alcohol catabolic process (GO:0034310) | 3.31629234 |
| 132 | nitrogen cycle metabolic process (GO:0071941) | 3.31588051 |
| 133 | O-glycan processing (GO:0016266) | 3.30280586 |
| 134 | positive regulation of digestive system process (GO:0060456) | 3.29820215 |
| 135 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.29617166 |
| 136 | regulation of telomerase activity (GO:0051972) | 3.28903575 |
| 137 | adhesion of symbiont to host (GO:0044406) | 3.27917452 |
| 138 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.27872876 |
| 139 | transcription from mitochondrial promoter (GO:0006390) | 3.26578243 |
| 140 | omega-hydroxylase P450 pathway (GO:0097267) | 3.25970900 |
| 141 | cGMP biosynthetic process (GO:0006182) | 3.24808983 |
| 142 | complement activation, classical pathway (GO:0006958) | 3.24730238 |
| 143 | positive regulation of cGMP metabolic process (GO:0030825) | 3.23947702 |
| 144 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.23917253 |
| 145 | vitamin transmembrane transport (GO:0035461) | 3.22681875 |
| 146 | DNA damage response, detection of DNA damage (GO:0042769) | 3.22534902 |
| 147 | regulation of cholesterol homeostasis (GO:2000188) | 3.22077214 |
| 148 | eosinophil migration (GO:0072677) | 3.21205250 |
| 149 | thyroid hormone metabolic process (GO:0042403) | 3.21201183 |
| 150 | thyroid hormone generation (GO:0006590) | 3.20581672 |
| 151 | histone H4-K16 acetylation (GO:0043984) | 3.20540876 |
| 152 | flavonoid metabolic process (GO:0009812) | 3.20228604 |
| 153 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.19436763 |
| 154 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.19436763 |
| 155 | glycosylceramide metabolic process (GO:0006677) | 3.19319279 |
| 156 | nuclear pore complex assembly (GO:0051292) | 3.19265180 |
| 157 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.18909889 |
| 158 | exogenous drug catabolic process (GO:0042738) | 3.17514077 |
| 159 | mitochondrion distribution (GO:0048311) | 3.16468906 |
| 160 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.16058541 |
| 161 | cGMP-mediated signaling (GO:0019934) | 3.15910773 |
| 162 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.14974018 |
| 163 | modified amino acid transport (GO:0072337) | 3.13547652 |
| 164 | sphingomyelin metabolic process (GO:0006684) | 3.12831325 |
| 165 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.12144042 |
| 166 | sulfur amino acid catabolic process (GO:0000098) | 3.10622842 |
| 167 | hypotonic response (GO:0006971) | 3.09108761 |
| 168 | fucosylation (GO:0036065) | 3.09079694 |
| 169 | positive regulation of protein deacetylation (GO:0090312) | 3.07169105 |
| 170 | cullin deneddylation (GO:0010388) | 3.07107930 |
| 171 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.07001928 |
| 172 | glucocorticoid biosynthetic process (GO:0006704) | 3.06410971 |
| 173 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.06346540 |
| 174 | peptide catabolic process (GO:0043171) | 3.05938499 |
| 175 | glycerol metabolic process (GO:0006071) | 3.05023722 |
| 176 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.03922226 |
| 177 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.03045611 |
| 178 | bile acid metabolic process (GO:0008206) | 3.02859402 |
| 179 | drug transmembrane transport (GO:0006855) | 3.02814954 |
| 180 | actin filament depolymerization (GO:0030042) | 3.01579415 |
| 181 | pseudouridine synthesis (GO:0001522) | 2.99366367 |
| 182 | drug transport (GO:0015893) | 2.99288336 |
| 183 | fatty acid derivative transport (GO:1901571) | 2.97812408 |
| 184 | icosanoid transport (GO:0071715) | 2.97812408 |
| 185 | vitamin transport (GO:0051180) | 2.97344378 |
| 186 | tachykinin receptor signaling pathway (GO:0007217) | 2.97085690 |
| 187 | plasma lipoprotein particle assembly (GO:0034377) | 2.96460401 |
| 188 | retinoic acid receptor signaling pathway (GO:0048384) | 2.95198552 |
| 189 | sulfur compound transport (GO:0072348) | 2.93609507 |
| 190 | fat-soluble vitamin metabolic process (GO:0006775) | 2.92941099 |
| 191 | daunorubicin metabolic process (GO:0044597) | 10.7909318 |
| 192 | polyketide metabolic process (GO:0030638) | 10.7909318 |
| 193 | doxorubicin metabolic process (GO:0044598) | 10.7909318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.22448120 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.22448120 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.22448120 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.98998957 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.47056903 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.13165351 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.49439906 |
| 8 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.28768320 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.27074557 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.12484684 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.11511852 |
| 12 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 3.04913786 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.91024948 |
| 14 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.90023790 |
| 15 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.82356567 |
| 16 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.80342485 |
| 17 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.73821392 |
| 18 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.70651682 |
| 19 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.61884144 |
| 20 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.60067236 |
| 21 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.52963054 |
| 22 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.44355418 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.41895418 |
| 24 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.36552023 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.35544890 |
| 26 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.28915611 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.26634849 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.21036232 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.20036510 |
| 30 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.16001266 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.13914625 |
| 32 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 2.11104339 |
| 33 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.10497970 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.10250770 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.08803179 |
| 36 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08417472 |
| 37 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.02724669 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.02446958 |
| 39 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.98362249 |
| 40 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.95678275 |
| 41 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.91341947 |
| 42 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.90658255 |
| 43 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.85523810 |
| 44 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.81836386 |
| 45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.80183711 |
| 46 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.78940554 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.74763683 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.73585867 |
| 49 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.69614301 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65214907 |
| 51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.63625229 |
| 52 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.63046855 |
| 53 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.60990731 |
| 54 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.60075355 |
| 55 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.59975395 |
| 56 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.57650935 |
| 57 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.55711334 |
| 58 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.54490283 |
| 59 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.53471993 |
| 60 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.51529443 |
| 61 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.50496270 |
| 62 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.49892575 |
| 63 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.47136227 |
| 64 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.45971702 |
| 65 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.43055813 |
| 66 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.42880873 |
| 67 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.42602903 |
| 68 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.38622023 |
| 69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37270979 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.35666920 |
| 71 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.34364038 |
| 72 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.34122366 |
| 73 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.32844880 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31068539 |
| 75 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30006269 |
| 76 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.29985305 |
| 77 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.29624407 |
| 78 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.28460476 |
| 79 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.27516629 |
| 80 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.25893582 |
| 81 | SA1_27219007_Chip-Seq_Bcells_Human | 1.25342602 |
| 82 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.25064293 |
| 83 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.24348764 |
| 84 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.21561082 |
| 85 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.20992263 |
| 86 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.20766798 |
| 87 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.17397955 |
| 88 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.17390809 |
| 89 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.17096337 |
| 90 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.16686869 |
| 91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16575881 |
| 92 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.16268444 |
| 93 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.15665686 |
| 94 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.14715375 |
| 95 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.13332844 |
| 96 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.12862913 |
| 97 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.11747389 |
| 98 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.11705672 |
| 99 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.11567059 |
| 100 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10866587 |
| 101 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.10134357 |
| 102 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.09349021 |
| 103 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.09056242 |
| 104 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07401144 |
| 105 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.05695160 |
| 106 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05605573 |
| 107 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.05038689 |
| 108 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04209712 |
| 109 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03790231 |
| 110 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02987749 |
| 111 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02413170 |
| 112 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01202429 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00703347 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99292060 |
| 115 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.98879088 |
| 116 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.97767393 |
| 117 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.97756669 |
| 118 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.95931083 |
| 119 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95722487 |
| 120 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.95644815 |
| 121 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.95640575 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94365192 |
| 123 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.93917946 |
| 124 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93890078 |
| 125 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93805430 |
| 126 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93317545 |
| 127 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92277533 |
| 128 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.92265630 |
| 129 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.91904349 |
| 130 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90712478 |
| 131 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.90456478 |
| 132 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.89134417 |
| 133 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88673790 |
| 134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88566123 |
| 135 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.88470655 |
| 136 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.86517462 |
| 137 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85732239 |
| 138 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.85660125 |
| 139 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.85314174 |
| 140 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.84976810 |
| 141 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.84089866 |
| 142 | P300_27268052_Chip-Seq_Bcells_Human | 0.83618791 |
| 143 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.83385342 |
| 144 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83345346 |
| 145 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83219498 |
| 146 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83172175 |
| 147 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82667705 |
| 148 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.82068078 |
| 149 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81624684 |
| 150 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81118934 |
| 151 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.80978540 |
| 152 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.80641517 |
| 153 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80242698 |
| 154 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80166568 |
| 155 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.79925282 |
| 156 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79835025 |
| 157 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.79773367 |
| 158 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.79717904 |
| 159 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78193902 |
| 160 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.77975227 |
| 161 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.77219386 |
| 162 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.76783711 |
| 163 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.75671196 |
| 164 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.75442612 |
| 165 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.75395776 |
| 166 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74964099 |
| 167 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72635057 |
| 168 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71890855 |
| 169 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.71415661 |
| 170 | ATF3_27146783_Chip-Seq_COLON_Human | 0.70911629 |
| 171 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.70890806 |
| 172 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70573179 |
| 173 | P68_20966046_ChIP-Seq_HELA_Human | 0.70181475 |
| 174 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69501338 |
| 175 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.68970761 |
| 176 | MYC_22102868_ChIP-Seq_BL_Human | 0.68786313 |
| 177 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.66387688 |
| 178 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.65010395 |
| 179 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.64812283 |
| 180 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.64729587 |
| 181 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.64446467 |
| 182 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.64184818 |
| 183 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.63516495 |
| 184 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.63438547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004264_abnormal_extraembryonic_tissu | 5.74840474 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.34463696 |
| 3 | MP0002254_reproductive_system_inflammat | 4.48812720 |
| 4 | MP0003011_delayed_dark_adaptation | 4.28523485 |
| 5 | MP0009379_abnormal_foot_pigmentation | 4.10787605 |
| 6 | MP0006292_abnormal_olfactory_placode | 3.74635685 |
| 7 | MP0004147_increased_porphyrin_level | 3.48645564 |
| 8 | MP0005365_abnormal_bile_salt | 3.36721623 |
| 9 | MP0005394_taste/olfaction_phenotype | 3.11096929 |
| 10 | MP0005499_abnormal_olfactory_system | 3.11096929 |
| 11 | MP0003890_abnormal_embryonic-extraembry | 2.98178975 |
| 12 | MP0004957_abnormal_blastocyst_morpholog | 2.97000718 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.87271640 |
| 14 | MP0004858_abnormal_nervous_system | 2.81376193 |
| 15 | MP0009840_abnormal_foam_cell | 2.68958298 |
| 16 | MP0005075_abnormal_melanosome_morpholog | 2.60868310 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.59283960 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.45111907 |
| 19 | MP0002277_abnormal_respiratory_mucosa | 2.45110890 |
| 20 | MP0001664_abnormal_digestion | 2.44833574 |
| 21 | MP0003283_abnormal_digestive_organ | 2.40369148 |
| 22 | MP0005257_abnormal_intraocular_pressure | 2.35020716 |
| 23 | MP0008057_abnormal_DNA_replication | 2.27561195 |
| 24 | MP0006035_abnormal_mitochondrial_morpho | 2.23585354 |
| 25 | MP0002332_abnormal_exercise_endurance | 2.22944282 |
| 26 | MP0003122_maternal_imprinting | 2.19589581 |
| 27 | MP0000678_abnormal_parathyroid_gland | 2.19413544 |
| 28 | MP0005360_urolithiasis | 2.09278891 |
| 29 | MP0002653_abnormal_ependyma_morphology | 2.01952329 |
| 30 | MP0001873_stomach_inflammation | 1.98234060 |
| 31 | MP0000490_abnormal_crypts_of | 1.97176578 |
| 32 | MP0004043_abnormal_pH_regulation | 1.93352944 |
| 33 | MP0003938_abnormal_ear_development | 1.88754011 |
| 34 | MP0003868_abnormal_feces_composition | 1.87887699 |
| 35 | MP0001663_abnormal_digestive_system | 1.86564016 |
| 36 | MP0001849_ear_inflammation | 1.82880556 |
| 37 | MP0001765_abnormal_ion_homeostasis | 1.81790917 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.74816277 |
| 39 | MP0003121_genomic_imprinting | 1.74782668 |
| 40 | MP0005409_darkened_coat_color | 1.71950602 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.69745591 |
| 42 | MP0005166_decreased_susceptibility_to | 1.66640091 |
| 43 | MP0005332_abnormal_amino_acid | 1.66422474 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.66072321 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.65205647 |
| 46 | MP0001672_abnormal_embryogenesis/_devel | 1.63206160 |
| 47 | MP0005380_embryogenesis_phenotype | 1.63206160 |
| 48 | MP0010030_abnormal_orbit_morphology | 1.60830913 |
| 49 | MP0005381_digestive/alimentary_phenotyp | 1.57837783 |
| 50 | MP0003315_abnormal_perineum_morphology | 1.56063277 |
| 51 | MP0000762_abnormal_tongue_morphology | 1.55384626 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 1.52816381 |
| 53 | MP0002088_abnormal_embryonic_growth/wei | 1.49551828 |
| 54 | MP0003984_embryonic_growth_retardation | 1.47932569 |
| 55 | MP0001764_abnormal_homeostasis | 1.43674088 |
| 56 | MP0003123_paternal_imprinting | 1.43102590 |
| 57 | MP0005266_abnormal_metabolism | 1.42088165 |
| 58 | MP0006082_CNS_inflammation | 1.38522076 |
| 59 | MP0003724_increased_susceptibility_to | 1.37264787 |
| 60 | MP0008961_abnormal_basal_metabolism | 1.30839011 |
| 61 | MP0000350_abnormal_cell_proliferation | 1.30447398 |
| 62 | MP0002932_abnormal_joint_morphology | 1.29402891 |
| 63 | MP0002127_abnormal_cardiovascular_syste | 1.27592195 |
| 64 | MP0002136_abnormal_kidney_physiology | 1.27538056 |
| 65 | MP0001188_hyperpigmentation | 1.27471209 |
| 66 | MP0002086_abnormal_extraembryonic_tissu | 1.26742884 |
| 67 | MP0005670_abnormal_white_adipose | 1.26314393 |
| 68 | MP0001293_anophthalmia | 1.23126770 |
| 69 | MP0002132_abnormal_respiratory_system | 1.18938471 |
| 70 | MP0000477_abnormal_intestine_morphology | 1.17155579 |
| 71 | MP0000538_abnormal_urinary_bladder | 1.16241773 |
| 72 | MP0008789_abnormal_olfactory_epithelium | 1.15209672 |
| 73 | MP0001756_abnormal_urination | 1.12857991 |
| 74 | MP0001501_abnormal_sleep_pattern | 1.11732444 |
| 75 | MP0002092_abnormal_eye_morphology | 1.11142757 |
| 76 | MP0003879_abnormal_hair_cell | 1.11070091 |
| 77 | MP0002118_abnormal_lipid_homeostasis | 1.10919535 |
| 78 | MP0002233_abnormal_nose_morphology | 1.10547376 |
| 79 | MP0001666_abnormal_nutrient_absorption | 1.09149660 |
| 80 | MP0003119_abnormal_digestive_system | 1.09038112 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 1.08941500 |
| 82 | MP0010234_abnormal_vibrissa_follicle | 1.08737971 |
| 83 | MP0002085_abnormal_embryonic_tissue | 1.08350299 |
| 84 | MP0003077_abnormal_cell_cycle | 1.08291341 |
| 85 | MP0008875_abnormal_xenobiotic_pharmacok | 1.07729608 |
| 86 | MP0000049_abnormal_middle_ear | 1.07609097 |
| 87 | MP0003806_abnormal_nucleotide_metabolis | 1.05277904 |
| 88 | MP0005377_hearing/vestibular/ear_phenot | 1.05082006 |
| 89 | MP0003878_abnormal_ear_physiology | 1.05082006 |
| 90 | MP0000230_abnormal_systemic_arterial | 1.02981035 |
| 91 | MP0002098_abnormal_vibrissa_morphology | 1.02889624 |
| 92 | MP0001845_abnormal_inflammatory_respons | 1.00358131 |
| 93 | MP0003693_abnormal_embryo_hatching | 1.00287421 |
| 94 | MP0010155_abnormal_intestine_physiology | 0.99746744 |
| 95 | MP0000462_abnormal_digestive_system | 0.98543424 |
| 96 | MP0003718_maternal_effect | 0.97967015 |
| 97 | MP0001485_abnormal_pinna_reflex | 0.96907161 |
| 98 | MP0009785_altered_susceptibility_to | 0.96317411 |
| 99 | MP0002796_impaired_skin_barrier | 0.95883507 |
| 100 | MP0005248_abnormal_Harderian_gland | 0.95820737 |
| 101 | MP0008872_abnormal_physiological_respon | 0.94654921 |
| 102 | MP0002166_altered_tumor_susceptibility | 0.94390242 |
| 103 | MP0005448_abnormal_energy_balance | 0.92701590 |
| 104 | MP0001730_embryonic_growth_arrest | 0.92480923 |
| 105 | MP0000432_abnormal_head_morphology | 0.91101175 |
| 106 | MP0003111_abnormal_nucleus_morphology | 0.90009265 |
| 107 | MP0000609_abnormal_liver_physiology | 0.88787772 |
| 108 | MP0001348_abnormal_lacrimal_gland | 0.88597798 |
| 109 | MP0002084_abnormal_developmental_patter | 0.86451130 |
| 110 | MP0001790_abnormal_immune_system | 0.85598282 |
| 111 | MP0005387_immune_system_phenotype | 0.85598282 |
| 112 | MP0002114_abnormal_axial_skeleton | 0.85048329 |
| 113 | MP0002822_catalepsy | 0.84739903 |
| 114 | MP0002970_abnormal_white_adipose | 0.84158909 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81636865 |
| 116 | MP0003436_decreased_susceptibility_to | 0.80105048 |
| 117 | MP0000313_abnormal_cell_death | 0.79594123 |
| 118 | MP0000537_abnormal_urethra_morphology | 0.79455559 |
| 119 | MP0005025_abnormal_response_to | 0.78343712 |
| 120 | MP0005451_abnormal_body_composition | 0.77801523 |
| 121 | MP0003137_abnormal_impulse_conducting | 0.77262798 |
| 122 | MP0002971_abnormal_brown_adipose | 0.76104723 |
| 123 | MP0003755_abnormal_palate_morphology | 0.75515584 |
| 124 | MP0000428_abnormal_craniofacial_morphol | 0.74941077 |
| 125 | MP0002396_abnormal_hematopoietic_system | 0.74793068 |
| 126 | MP0005535_abnormal_body_temperature | 0.74453623 |
| 127 | MP0003787_abnormal_imprinting | 0.71508320 |
| 128 | MP0005023_abnormal_wound_healing | 0.71424199 |
| 129 | MP0010678_abnormal_skin_adnexa | 0.70358454 |
| 130 | MP0003935_abnormal_craniofacial_develop | 0.69441283 |
| 131 | MP0003329_amyloid_beta_deposits | 0.68676146 |
| 132 | MP0005319_abnormal_enzyme/_coenzyme | 0.68564601 |
| 133 | MP0003191_abnormal_cellular_cholesterol | 0.68342369 |
| 134 | MP0002006_tumorigenesis | 0.68253303 |
| 135 | MP0008932_abnormal_embryonic_tissue | 0.67480358 |
| 136 | MP0001697_abnormal_embryo_size | 0.67334774 |
| 137 | MP0002080_prenatal_lethality | 0.66974986 |
| 138 | MP0005645_abnormal_hypothalamus_physiol | 0.66796492 |
| 139 | MP0009642_abnormal_blood_homeostasis | 0.66732734 |
| 140 | MP0008469_abnormal_protein_level | 0.66190346 |
| 141 | MP0009764_decreased_sensitivity_to | 0.66154425 |
| 142 | MP0001835_abnormal_antigen_presentation | 0.65801057 |
| 143 | MP0008770_decreased_survivor_rate | 0.65516305 |
| 144 | MP0004197_abnormal_fetal_growth/weight/ | 0.64690232 |
| 145 | MP0003937_abnormal_limbs/digits/tail_de | 0.64038891 |
| 146 | MP0005085_abnormal_gallbladder_physiolo | 0.63932933 |
| 147 | MP0002148_abnormal_hypersensitivity_rea | 0.63677025 |
| 148 | MP0005310_abnormal_salivary_gland | 0.61905678 |
| 149 | MP0004270_analgesia | 0.61049630 |
| 150 | MP0009333_abnormal_splenocyte_physiolog | 0.60462126 |
| 151 | MP0001533_abnormal_skeleton_physiology | 0.60127713 |
| 152 | MP0005165_increased_susceptibility_to | 0.60098413 |
| 153 | MP0003866_abnormal_defecation | 0.58491770 |
| 154 | MP0004782_abnormal_surfactant_physiolog | 0.58482901 |
| 155 | MP0003252_abnormal_bile_duct | 0.58312346 |
| 156 | MP0009115_abnormal_fat_cell | 0.57994965 |
| 157 | MP0000377_abnormal_hair_follicle | 0.57773109 |
| 158 | MP0004381_abnormal_hair_follicle | 0.57694792 |
| 159 | MP0005167_abnormal_blood-brain_barrier | 0.57383880 |
| 160 | MP0005391_vision/eye_phenotype | 0.57260897 |
| 161 | MP0004019_abnormal_vitamin_homeostasis | 0.57178050 |
| 162 | MP0004947_skin_inflammation | 0.57095432 |
| 163 | MP0005501_abnormal_skin_physiology | 0.56687313 |
| 164 | MP0008004_abnormal_stomach_pH | 0.56496393 |
| 165 | MP0003953_abnormal_hormone_level | 0.54802670 |
| 166 | MP0001881_abnormal_mammary_gland | 0.54127579 |
| 167 | MP0000249_abnormal_blood_vessel | 0.53608622 |
| 168 | MP0001800_abnormal_humoral_immune | 0.52699497 |
| 169 | MP0000604_amyloidosis | 0.52471629 |
| 170 | MP0002896_abnormal_bone_mineralization | 0.51695118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 8.58783278 |
| 2 | Bilateral microphthalmos (HP:0007633) | 7.17036930 |
| 3 | Hyperactive renin-angiotensin system (HP:0000841) | 6.41013015 |
| 4 | Decreased circulating renin level (HP:0003351) | 6.05476804 |
| 5 | Hypochromic microcytic anemia (HP:0004840) | 5.69821714 |
| 6 | Hydroxyprolinuria (HP:0003080) | 5.59509509 |
| 7 | Abnormality of proline metabolism (HP:0010907) | 5.59509509 |
| 8 | Metabolic alkalosis (HP:0200114) | 5.52830960 |
| 9 | Multiple enchondromatosis (HP:0005701) | 5.48487327 |
| 10 | Abnormality of renin-angiotensin system (HP:0000847) | 5.15888169 |
| 11 | Hepatoblastoma (HP:0002884) | 5.03301394 |
| 12 | Chronic diarrhea (HP:0002028) | 4.73749664 |
| 13 | Alkalosis (HP:0001948) | 4.70720263 |
| 14 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.54356278 |
| 15 | Rib fusion (HP:0000902) | 4.53002101 |
| 16 | Abnormality of vitamin B metabolism (HP:0004340) | 4.25598736 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 4.21391681 |
| 18 | Abnormality of the lower motor neuron (HP:0002366) | 4.20995523 |
| 19 | Ependymoma (HP:0002888) | 4.05437522 |
| 20 | Fat malabsorption (HP:0002630) | 3.90854312 |
| 21 | Partial duplication of thumb phalanx (HP:0009944) | 3.74444824 |
| 22 | Hypobetalipoproteinemia (HP:0003563) | 3.71277173 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.60088345 |
| 24 | Confusion (HP:0001289) | 3.59226235 |
| 25 | Rhabdomyosarcoma (HP:0002859) | 3.57817406 |
| 26 | Neoplasm of striated muscle (HP:0009728) | 3.54166642 |
| 27 | Rectovaginal fistula (HP:0000143) | 3.52258409 |
| 28 | Rectal fistula (HP:0100590) | 3.52258409 |
| 29 | Congenital sensorineural hearing impairment (HP:0008527) | 3.49533643 |
| 30 | Widely patent fontanelles and sutures (HP:0004492) | 3.48521738 |
| 31 | Trismus (HP:0000211) | 3.44406621 |
| 32 | Abnormal cartilage morphology (HP:0002763) | 3.42610845 |
| 33 | Abnormality of vitamin metabolism (HP:0100508) | 3.35516634 |
| 34 | Abnormality of the phalanges of the hallux (HP:0010057) | 3.35035736 |
| 35 | Aplasia/hypoplasia of the humerus (HP:0006507) | 3.34862485 |
| 36 | Abdominal distention (HP:0003270) | 3.33145265 |
| 37 | Short humerus (HP:0005792) | 3.33020934 |
| 38 | Glycosuria (HP:0003076) | 3.32719549 |
| 39 | Abnormality of urine glucose concentration (HP:0011016) | 3.32719549 |
| 40 | Hyperaldosteronism (HP:0000859) | 3.31058698 |
| 41 | Testicular atrophy (HP:0000029) | 3.23770729 |
| 42 | Partial duplication of the phalanx of hand (HP:0009999) | 3.23675015 |
| 43 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.22484759 |
| 44 | Acanthocytosis (HP:0001927) | 3.22257498 |
| 45 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.20090944 |
| 46 | Hypoplasia of the fovea (HP:0007750) | 3.20090944 |
| 47 | Abnormality of chloride homeostasis (HP:0011422) | 3.18667924 |
| 48 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.17622642 |
| 49 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.16131199 |
| 50 | Malnutrition (HP:0004395) | 3.15622487 |
| 51 | Intestinal fistula (HP:0100819) | 3.12503792 |
| 52 | Cheilitis (HP:0100825) | 3.12280885 |
| 53 | Fused cervical vertebrae (HP:0002949) | 3.11759650 |
| 54 | Ragged-red muscle fibers (HP:0003200) | 3.10365010 |
| 55 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.09254441 |
| 56 | Vaginal fistula (HP:0004320) | 3.07286982 |
| 57 | Abnormality of the salivary glands (HP:0010286) | 3.04502403 |
| 58 | Villous atrophy (HP:0011473) | 2.98435445 |
| 59 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.98435445 |
| 60 | Embryonal renal neoplasm (HP:0011794) | 2.95976338 |
| 61 | Reduced antithrombin III activity (HP:0001976) | 2.92759825 |
| 62 | Thin bony cortex (HP:0002753) | 2.92225919 |
| 63 | Hypokalemia (HP:0002900) | 2.92083790 |
| 64 | Nausea (HP:0002018) | 2.90378284 |
| 65 | Pigmentary retinal degeneration (HP:0001146) | 2.86608472 |
| 66 | Chromsome breakage (HP:0040012) | 2.83463654 |
| 67 | Proximal tubulopathy (HP:0000114) | 2.82774070 |
| 68 | Right ventricular cardiomyopathy (HP:0011663) | 2.79539695 |
| 69 | Microretrognathia (HP:0000308) | 2.79366666 |
| 70 | Astrocytoma (HP:0009592) | 2.78865887 |
| 71 | Abnormality of the astrocytes (HP:0100707) | 2.78865887 |
| 72 | Bifid tongue (HP:0010297) | 2.76083751 |
| 73 | Anomalous pulmonary venous return (HP:0010772) | 2.75313745 |
| 74 | Flat acetabular roof (HP:0003180) | 2.74040630 |
| 75 | Shawl scrotum (HP:0000049) | 2.73785653 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.68576091 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.68576091 |
| 78 | Eczematoid dermatitis (HP:0000976) | 2.68451428 |
| 79 | Xanthomatosis (HP:0000991) | 2.68270924 |
| 80 | Hyperammonemia (HP:0001987) | 2.67677947 |
| 81 | Abnormality of glycine metabolism (HP:0010895) | 2.65305691 |
| 82 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.65305691 |
| 83 | Large earlobe (HP:0009748) | 2.64009436 |
| 84 | Hyperparathyroidism (HP:0000843) | 2.63726675 |
| 85 | Hemorrhage of the eye (HP:0011885) | 2.61444068 |
| 86 | Nephrolithiasis (HP:0000787) | 2.60033844 |
| 87 | Impulsivity (HP:0100710) | 2.59657291 |
| 88 | Abnormal lung lobation (HP:0002101) | 2.59520419 |
| 89 | Conjugated hyperbilirubinemia (HP:0002908) | 2.57749405 |
| 90 | Abnormality of potassium homeostasis (HP:0011042) | 2.56389573 |
| 91 | Increased purine levels (HP:0004368) | 2.54805897 |
| 92 | Hyperuricemia (HP:0002149) | 2.54805897 |
| 93 | Amyotrophic lateral sclerosis (HP:0007354) | 2.54359700 |
| 94 | Wide cranial sutures (HP:0010537) | 2.53069189 |
| 95 | Horizontal nystagmus (HP:0000666) | 2.51725252 |
| 96 | Preauricular pit (HP:0004467) | 2.50475108 |
| 97 | Periauricular skin pits (HP:0100277) | 2.50475108 |
| 98 | Intrahepatic cholestasis (HP:0001406) | 2.44939007 |
| 99 | Glomerulonephritis (HP:0000099) | 2.44913038 |
| 100 | Ileus (HP:0002595) | 2.44823137 |
| 101 | Cerebral palsy (HP:0100021) | 2.43506983 |
| 102 | Progressive muscle weakness (HP:0003323) | 2.43337485 |
| 103 | Hypochromic anemia (HP:0001931) | 2.41916029 |
| 104 | Sensory axonal neuropathy (HP:0003390) | 2.41709536 |
| 105 | Hypophosphatemia (HP:0002148) | 2.41345357 |
| 106 | Posterior subcapsular cataract (HP:0007787) | 2.39672249 |
| 107 | Nasolacrimal duct obstruction (HP:0000579) | 2.37095379 |
| 108 | Megaloblastic anemia (HP:0001889) | 2.35415239 |
| 109 | Abnormality of the pulmonary veins (HP:0011718) | 2.35338633 |
| 110 | Metabolic acidosis (HP:0001942) | 2.35107781 |
| 111 | Hyponatremia (HP:0002902) | 2.34885132 |
| 112 | Pili torti (HP:0003777) | 2.33385980 |
| 113 | Combined immunodeficiency (HP:0005387) | 2.33260572 |
| 114 | Tongue fasciculations (HP:0001308) | 2.32989828 |
| 115 | Hypotension (HP:0002615) | 2.31688288 |
| 116 | Abnormality of the fovea (HP:0000493) | 2.31672766 |
| 117 | Preauricular skin tag (HP:0000384) | 2.30912931 |
| 118 | Nephritis (HP:0000123) | 2.29444125 |
| 119 | Focal segmental glomerulosclerosis (HP:0000097) | 2.29235541 |
| 120 | Enlarged epiphyses (HP:0010580) | 2.28443385 |
| 121 | Hyperventilation (HP:0002883) | 2.28106008 |
| 122 | Abnormality of purine metabolism (HP:0004352) | 2.26020378 |
| 123 | Abnormal urine phosphate concentration (HP:0012599) | 2.24364313 |
| 124 | Hyperphosphaturia (HP:0003109) | 2.23353954 |
| 125 | Abnormality of magnesium homeostasis (HP:0004921) | 2.22699492 |
| 126 | Increased connective tissue (HP:0009025) | 2.22521969 |
| 127 | Complement deficiency (HP:0004431) | 2.21697048 |
| 128 | Pancreatitis (HP:0001733) | 2.21553020 |
| 129 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.21328473 |
| 130 | Abnormality of the musculature of the hand (HP:0001421) | 2.20197122 |
| 131 | Tetraplegia (HP:0002445) | 2.20165846 |
| 132 | Abnormality of nucleobase metabolism (HP:0010932) | 2.20034159 |
| 133 | Abnormality of complement system (HP:0005339) | 2.19008559 |
| 134 | Steatorrhea (HP:0002570) | 2.18601221 |
| 135 | 3-Methylglutaconic aciduria (HP:0003535) | 2.16967712 |
| 136 | Growth hormone excess (HP:0000845) | 2.16566617 |
| 137 | Hyperphosphatemia (HP:0002905) | 2.15338460 |
| 138 | Delayed epiphyseal ossification (HP:0002663) | 2.11384134 |
| 139 | Abnormal tarsal ossification (HP:0008369) | 2.08852732 |
| 140 | Generalized hypotonia (HP:0001290) | 2.07239642 |
| 141 | Abnormal hair laboratory examination (HP:0003328) | 2.07024501 |
| 142 | Muscle fibrillation (HP:0010546) | 2.07008421 |
| 143 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.06973317 |
| 144 | Meckel diverticulum (HP:0002245) | 2.06751982 |
| 145 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.06292975 |
| 146 | Glioma (HP:0009733) | 2.06143000 |
| 147 | Dehydration (HP:0001944) | 2.06080760 |
| 148 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.05477942 |
| 149 | Protuberant abdomen (HP:0001538) | 2.05213502 |
| 150 | Renal tubular acidosis (HP:0001947) | 2.03296919 |
| 151 | Pendular nystagmus (HP:0012043) | 2.02154706 |
| 152 | Gout (HP:0001997) | 2.01842599 |
| 153 | Short 5th finger (HP:0009237) | 1.99749286 |
| 154 | Potter facies (HP:0002009) | 1.98791843 |
| 155 | Facial shape deformation (HP:0011334) | 1.98791843 |
| 156 | Abnormality of the pubic bones (HP:0003172) | 1.97030636 |
| 157 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.96431888 |
| 158 | Difficulty running (HP:0009046) | 1.96420383 |
| 159 | Skin tags (HP:0010609) | 1.96067112 |
| 160 | Glossoptosis (HP:0000162) | 1.95799023 |
| 161 | Hypopigmentation of the fundus (HP:0007894) | 1.95326550 |
| 162 | Adenoma sebaceum (HP:0009720) | 1.94776978 |
| 163 | Angiofibromas (HP:0010615) | 1.94776978 |
| 164 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.94578909 |
| 165 | Syncope (HP:0001279) | 1.94483013 |
| 166 | Abnormal biliary tract morphology (HP:0012440) | 1.94337190 |
| 167 | Skin pits (HP:0100276) | 1.94174770 |
| 168 | Flattened epiphyses (HP:0003071) | 1.93288285 |
| 169 | Micronodular cirrhosis (HP:0001413) | 1.93242634 |
| 170 | Abnormality of the costochondral junction (HP:0000919) | 1.92887805 |
| 171 | Adrenal overactivity (HP:0002717) | 1.92470292 |
| 172 | Abnormal hemoglobin (HP:0011902) | 1.91514110 |
| 173 | Multifactorial inheritance (HP:0001426) | 1.91025527 |
| 174 | Hypoplastic scapulae (HP:0000882) | 1.89635017 |
| 175 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.89635017 |
| 176 | Abnormality of the ileum (HP:0001549) | 1.89496577 |
| 177 | Hyperkalemia (HP:0002153) | 1.89083709 |
| 178 | Symptomatic seizures (HP:0011145) | 1.88146466 |
| 179 | Duplication of thumb phalanx (HP:0009942) | 1.87936880 |
| 180 | Premature ovarian failure (HP:0008209) | 1.87809438 |
| 181 | Hyperglycinuria (HP:0003108) | 1.87601317 |
| 182 | Hypolipoproteinemia (HP:0010981) | 1.87427812 |
| 183 | Increased serum pyruvate (HP:0003542) | 1.87125126 |
| 184 | Abnormality of glycolysis (HP:0004366) | 1.87125126 |
| 185 | Progressive external ophthalmoplegia (HP:0000590) | 1.86316165 |
| 186 | Type I transferrin isoform profile (HP:0003642) | 1.86193267 |
| 187 | Lethargy (HP:0001254) | 1.85785651 |
| 188 | Spastic tetraparesis (HP:0001285) | 1.85315166 |
| 189 | Fasciculations (HP:0002380) | 1.83604473 |
| 190 | Microvesicular hepatic steatosis (HP:0001414) | 1.83023517 |
| 191 | Abnormality of chromosome segregation (HP:0002916) | 1.82386338 |
| 192 | Bone cyst (HP:0012062) | 1.81549926 |
| 193 | Glomerulosclerosis (HP:0000096) | 1.81517305 |
| 194 | Petechiae (HP:0000967) | 1.77255426 |
| 195 | Irritability (HP:0000737) | 1.75071261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.97936365 |
| 2 | ACVR1B | 7.06917552 |
| 3 | GRK5 | 5.14649946 |
| 4 | GRK6 | 4.88543216 |
| 5 | ERN1 | 4.47505140 |
| 6 | GRK1 | 3.44070678 |
| 7 | ADRBK2 | 3.06772101 |
| 8 | STK39 | 2.91203655 |
| 9 | TTK | 2.89693835 |
| 10 | CSF1R | 2.54812450 |
| 11 | OXSR1 | 2.52397021 |
| 12 | MATK | 2.44821276 |
| 13 | TYRO3 | 2.43204816 |
| 14 | PRKG2 | 2.32780097 |
| 15 | TGFBR2 | 2.25746284 |
| 16 | GRK7 | 2.13989643 |
| 17 | STK10 | 2.13599907 |
| 18 | MAPK7 | 2.00015639 |
| 19 | EPHA2 | 1.95122271 |
| 20 | PTK6 | 1.93997900 |
| 21 | MOS | 1.84331716 |
| 22 | PDK2 | 1.78175006 |
| 23 | WNK1 | 1.76828620 |
| 24 | AKT3 | 1.60152355 |
| 25 | FGFR4 | 1.50977988 |
| 26 | PAK4 | 1.47291901 |
| 27 | STK24 | 1.46808070 |
| 28 | CDK7 | 1.44335820 |
| 29 | MST1R | 1.43994330 |
| 30 | MAP3K2 | 1.38857830 |
| 31 | MAP3K12 | 1.35448154 |
| 32 | MST4 | 1.33346717 |
| 33 | NTRK1 | 1.30810022 |
| 34 | LMTK2 | 1.26796979 |
| 35 | CAMK4 | 1.25697267 |
| 36 | MAP2K6 | 1.25441894 |
| 37 | TNIK | 1.24179610 |
| 38 | TYK2 | 1.18154344 |
| 39 | EPHA3 | 1.17877791 |
| 40 | CHEK2 | 1.16483425 |
| 41 | MAP3K10 | 1.15464165 |
| 42 | MYLK | 1.12744242 |
| 43 | WNK4 | 1.09372790 |
| 44 | PLK1 | 1.05066973 |
| 45 | ADRBK1 | 0.99669868 |
| 46 | MARK2 | 0.98387685 |
| 47 | MAP4K1 | 0.97098157 |
| 48 | CASK | 0.96948861 |
| 49 | TESK1 | 0.95418804 |
| 50 | NLK | 0.92227898 |
| 51 | NME1 | 0.88949573 |
| 52 | EPHB1 | 0.86276592 |
| 53 | MAP3K7 | 0.86248386 |
| 54 | MAP2K4 | 0.83674442 |
| 55 | MAP3K1 | 0.82130419 |
| 56 | HIPK2 | 0.80490267 |
| 57 | CSK | 0.80132507 |
| 58 | IRAK1 | 0.79131683 |
| 59 | MAP2K2 | 0.77665544 |
| 60 | NEK2 | 0.77007310 |
| 61 | FGFR3 | 0.76864777 |
| 62 | PRKCI | 0.73267870 |
| 63 | AKT2 | 0.73082443 |
| 64 | FER | 0.71761838 |
| 65 | EPHA4 | 0.71206054 |
| 66 | PDPK1 | 0.68530185 |
| 67 | FRK | 0.67974404 |
| 68 | RIPK1 | 0.67497809 |
| 69 | ALK | 0.66357507 |
| 70 | ERBB2 | 0.65849490 |
| 71 | CDK19 | 0.65393859 |
| 72 | CDC42BPA | 0.64930165 |
| 73 | PRKAA2 | 0.62006231 |
| 74 | CAMK2D | 0.58720514 |
| 75 | CHEK1 | 0.57197454 |
| 76 | MET | 0.56490241 |
| 77 | EIF2AK2 | 0.54123806 |
| 78 | ABL2 | 0.53910306 |
| 79 | * PRKCA | 0.53803927 |
| 80 | NUAK1 | 0.51895408 |
| 81 | RPS6KB2 | 0.51657208 |
| 82 | AURKB | 0.50633498 |
| 83 | MAPK11 | 0.49916925 |
| 84 | PRKCZ | 0.49880371 |
| 85 | PDK1 | 0.48993526 |
| 86 | RIPK4 | 0.48228827 |
| 87 | PTK2 | 0.47650110 |
| 88 | DYRK1B | 0.47139460 |
| 89 | IKBKE | 0.46773375 |
| 90 | TBK1 | 0.45461743 |
| 91 | PAK1 | 0.45335787 |
| 92 | NEK1 | 0.45295489 |
| 93 | SRC | 0.43652421 |
| 94 | WEE1 | 0.43579207 |
| 95 | TESK2 | 0.43338104 |
| 96 | LATS2 | 0.42385005 |
| 97 | TXK | 0.40643860 |
| 98 | * PRKACG | 0.40549156 |
| 99 | TAOK1 | 0.40469826 |
| 100 | DDR2 | 0.40430735 |
| 101 | PIM1 | 0.37694606 |
| 102 | ZAP70 | 0.37260466 |
| 103 | MTOR | 0.36728855 |
| 104 | BUB1 | 0.36184474 |
| 105 | MAP3K9 | 0.35991197 |
| 106 | MAPK12 | 0.35977009 |
| 107 | AURKA | 0.35605179 |
| 108 | PRKCD | 0.35235115 |
| 109 | CDK2 | 0.34380652 |
| 110 | LYN | 0.33977838 |
| 111 | DAPK2 | 0.33478932 |
| 112 | IGF1R | 0.33058765 |
| 113 | JAK2 | 0.32589737 |
| 114 | PRKCQ | 0.32468677 |
| 115 | KIT | 0.31669974 |
| 116 | PIK3CA | 0.30550778 |
| 117 | CSNK1E | 0.30327282 |
| 118 | MAPKAPK2 | 0.29408283 |
| 119 | MAP3K8 | 0.27445225 |
| 120 | CDK4 | 0.27379928 |
| 121 | RET | 0.26400457 |
| 122 | MAP2K1 | 0.26398700 |
| 123 | BMX | 0.26195926 |
| 124 | ITK | 0.24646135 |
| 125 | IKBKB | 0.24587837 |
| 126 | KSR2 | 0.24583378 |
| 127 | DMPK | 0.24393862 |
| 128 | CAMK2G | 0.23880172 |
| 129 | RPS6KA2 | 0.23784179 |
| 130 | LATS1 | 0.22171250 |
| 131 | CSNK1A1 | 0.21749115 |
| 132 | PRKAA1 | 0.21535407 |
| 133 | STK38 | 0.21171841 |
| 134 | FYN | 0.20605944 |
| 135 | STK38L | 0.20574901 |
| 136 | TAOK2 | 0.20566923 |
| 137 | PDGFRA | 0.19101541 |
| 138 | CDC7 | 0.18685606 |
| 139 | FGR | 0.18394351 |
| 140 | SYK | 0.17936920 |
| 141 | ATM | 0.17933609 |
| 142 | JAK1 | 0.17908973 |
| 143 | EPHB2 | 0.17694439 |
| 144 | INSRR | 0.17675908 |
| 145 | BMPR2 | 0.17631354 |
| 146 | STK3 | 0.17079763 |
| 147 | INSR | 0.15451895 |
| 148 | CDK15 | 0.13306761 |
| 149 | MAP3K11 | 0.13134172 |
| 150 | GSK3B | 0.13054273 |
| 151 | NME2 | 0.12833762 |
| 152 | CDK11A | 0.12794508 |
| 153 | GSK3A | 0.11904184 |
| 154 | PRKACB | 0.11860378 |
| 155 | CDK1 | 0.11544826 |
| 156 | MAPK1 | 0.11529285 |
| 157 | ICK | 0.11063826 |
| 158 | PRKACA | 0.10370617 |
| 159 | MAPK10 | 0.10165675 |
| 160 | PBK | 0.09797304 |
| 161 | CDK18 | 0.08736535 |
| 162 | MAPK4 | 0.08176976 |
| 163 | MAPK14 | 0.08093241 |
| 164 | PRKD2 | 0.06913579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 5.23311469 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.05815798 |
| 3 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 4.73632910 |
| 4 | Galactose metabolism_Homo sapiens_hsa00052 | 3.48705645 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.05894599 |
| 6 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.89225906 |
| 7 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.70003112 |
| 8 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.63954028 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.61760879 |
| 10 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.60187144 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.49310142 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46477415 |
| 13 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.45827960 |
| 14 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.44543153 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39593375 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.93591946 |
| 17 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.80554341 |
| 18 | Mineral absorption_Homo sapiens_hsa04978 | 1.77878194 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.75284450 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.68926073 |
| 21 | Ribosome_Homo sapiens_hsa03010 | 1.61995026 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.59055912 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.58825157 |
| 24 | Thyroid cancer_Homo sapiens_hsa05216 | 1.49342005 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.45749385 |
| 26 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.41292617 |
| 27 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.39960713 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.37265473 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.35326446 |
| 30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.32501977 |
| 31 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.27138470 |
| 32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.17859044 |
| 33 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.14868297 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14033404 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09014374 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.08483982 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.02396191 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.00840848 |
| 39 | RNA transport_Homo sapiens_hsa03013 | 1.00628794 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.00066221 |
| 41 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.97028319 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96604133 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.96122190 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95479818 |
| 45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.95231404 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95155394 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94736067 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94437356 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 0.91335485 |
| 50 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.90416846 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90096686 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88964752 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.84879840 |
| 54 | Homologous recombination_Homo sapiens_hsa03440 | 0.82947386 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82372700 |
| 56 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.80618346 |
| 57 | Tight junction_Homo sapiens_hsa04530 | 0.80512598 |
| 58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.78805634 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78492846 |
| 60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.73188784 |
| 61 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72124642 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72067685 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68939870 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66861745 |
| 65 | Mismatch repair_Homo sapiens_hsa03430 | 0.64128675 |
| 66 | DNA replication_Homo sapiens_hsa03030 | 0.62192838 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62142405 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62029302 |
| 69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61951287 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61842717 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61429752 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.60919011 |
| 73 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.58455409 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58320768 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.56685146 |
| 76 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56140568 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55051913 |
| 78 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.52313940 |
| 79 | Cell cycle_Homo sapiens_hsa04110 | 0.51211539 |
| 80 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.49895739 |
| 81 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49127245 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48752392 |
| 83 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.48032239 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47998542 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47061442 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46697101 |
| 87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45147542 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44688225 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44603335 |
| 90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44183918 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44139551 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44127860 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43273096 |
| 94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43146762 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43042629 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41226629 |
| 97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.40174790 |
| 98 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.39666742 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38104335 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37248841 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37236666 |
| 102 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36623398 |
| 103 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35538164 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.34962859 |
| 105 | Renin secretion_Homo sapiens_hsa04924 | 0.34479417 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.32921992 |
| 107 | Leishmaniasis_Homo sapiens_hsa05140 | 0.31347064 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.31087834 |
| 109 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.30990824 |
| 110 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.30928510 |
| 111 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.29103627 |
| 112 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29097359 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28902081 |
| 114 | RNA degradation_Homo sapiens_hsa03018 | 0.28824365 |
| 115 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.26398780 |
| 116 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.26229454 |
| 117 | Pertussis_Homo sapiens_hsa05133 | 0.24763749 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.23417479 |
| 119 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.22520849 |
| 120 | Adherens junction_Homo sapiens_hsa04520 | 0.22470317 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | 0.22423291 |
| 122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21785856 |
| 123 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.21420214 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21011336 |
| 125 | Viral myocarditis_Homo sapiens_hsa05416 | 0.20715636 |
| 126 | RNA polymerase_Homo sapiens_hsa03020 | 0.20462475 |
| 127 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.19897289 |
| 128 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.19063195 |
| 129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.18776509 |
| 130 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.18688917 |
| 131 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.18586377 |
| 132 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.18140514 |
| 133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.15357586 |
| 134 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.15232488 |
| 135 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.14909364 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.13205714 |
| 137 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12876949 |
| 138 | ABC transporters_Homo sapiens_hsa02010 | 0.11908969 |
| 139 | Insulin secretion_Homo sapiens_hsa04911 | 0.11648670 |
| 140 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.10482964 |
| 141 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.06318249 |
| 142 | Cocaine addiction_Homo sapiens_hsa05030 | 0.04531110 |
| 143 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.03032324 |
| 144 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.02671426 |
| 145 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.00672332 |
| 146 | beta-Alanine metabolism_Homo sapiens_hsa00410 | -0.0332951 |
| 147 | Tuberculosis_Homo sapiens_hsa05152 | -0.0308931 |
| 148 | Chemokine signaling pathway_Homo sapiens_hsa04062 | -0.0071070 |

